After the pioneering report presenting the first evidence for the presence of natural antibodies directed to recombinant human full-length tau in three IVIG products [65], studies have been undertaken to show also the enrichment of IVIGs with antibodies against various tau regions [66] and AD-specific phosphorylated tau forms [67]. Here, MAPT is linked to Alzheimer disease.